Cite
HARVARD Citation
Forster, M. et al. (n.d.). 316 Phase I study of lurbinectedin (PM01183) in combination with cisplatin (C) with or without aprepitant (Ap) in patients (pts) with advanced solid tumors. European journal of cancer. pp. S60-. [Online].